THE EFFECT OF SELENIUM ON IMMUNOGENICITY OF INFLUENZA VACCINE IN THE ELDERLY: A CASE-CONTROL DOUBLE-BLINDED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JANBAKHSH ALIREZA; MANSOURI FEIZOLLAH; VAZIRI SIAVASH; SAYAD BABAK; AFSHARIAN MANDANA; REZAEI MANSOUR; HEIDARI SOHRAB

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Kermanshah University of Medical Sciences Year:2016 | Volume:20 | Issue:1 Page(s): 17-20

Download Full-Text

View:

862

Download:

170

Cites:

Information Journal Paper

Title

THE EFFECT OF SELENIUM ON IMMUNOGENICITY OF INFLUENZA VACCINE IN THE ELDERLY: A CASE-CONTROL DOUBLE-BLINDED CLINICAL TRIAL

Author(s)

Keywords

INFLUENZA

VACCINE

SELENIUM

ELDERLY PATIENTS

Abstract

Introduction: INFLUENZA can cause more severe diseases and higher rate of morbidity and mortality in the elderly population. Therefore, they should receive INFLUENZA VACCINE annually. However, the host response to VACCINE is less in older individuals.On the other hand, SELENIUM can act as a stimulator of the immune system and cause increased immunity and response to VACCINE. This study was carried out to determine the effect of SELENIUM on antibody production against INFLUENZA VACCINE. By verifying this effect, SELENIUM can be recommended as an adjuvant therapy in the elderly.Methods: A total of 110 subjects were selected at Infectious Diseases Research Center of Imam Reza Hospital in Kermanshah. They were divided into two groups of adjuvant (N=56) and placebo (N=54). The adjuvant group received INFLUENZA VACCINE and SELENIUM tablet. The placebo group received INFLUENZA VACCINE and placebo tablet. Venous blood samples were taken before and four weeks after vaccination and the results were compared between the two groups.Results: Seroconversion, seroprotection, and geometric mean titer (GMT) for three strains (H1N1, H3N2, and B) were assessed. The seroconversion and GMT rates against INFLUENZA B VACCINE component were significantly higher in adjuvant group than placebo group.Conclusion: Considering the ability of SELENIUM in induction of a better response to INFLUENZA VACCINE in older people as well as its low cost and accessibility, SELENIUM can be used to increase antibody level in such cases.

Cites

No record.

References

No record.

Cite

APA: Copy

JANBAKHSH, ALIREZA, MANSOURI, FEIZOLLAH, VAZIRI, SIAVASH, SAYAD, BABAK, AFSHARIAN, MANDANA, REZAEI, MANSOUR, & HEIDARI, SOHRAB. (2016). THE EFFECT OF SELENIUM ON IMMUNOGENICITY OF INFLUENZA VACCINE IN THE ELDERLY: A CASE-CONTROL DOUBLE-BLINDED CLINICAL TRIAL. JOURNAL OF KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES (BEHBOOD), 20(1), 17-20. SID. https://sid.ir/paper/695709/en

Vancouver: Copy

JANBAKHSH ALIREZA, MANSOURI FEIZOLLAH, VAZIRI SIAVASH, SAYAD BABAK, AFSHARIAN MANDANA, REZAEI MANSOUR, HEIDARI SOHRAB. THE EFFECT OF SELENIUM ON IMMUNOGENICITY OF INFLUENZA VACCINE IN THE ELDERLY: A CASE-CONTROL DOUBLE-BLINDED CLINICAL TRIAL. JOURNAL OF KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES (BEHBOOD)[Internet]. 2016;20(1):17-20. Available from: https://sid.ir/paper/695709/en

IEEE: Copy

ALIREZA JANBAKHSH, FEIZOLLAH MANSOURI, SIAVASH VAZIRI, BABAK SAYAD, MANDANA AFSHARIAN, MANSOUR REZAEI, and SOHRAB HEIDARI, “THE EFFECT OF SELENIUM ON IMMUNOGENICITY OF INFLUENZA VACCINE IN THE ELDERLY: A CASE-CONTROL DOUBLE-BLINDED CLINICAL TRIAL,” JOURNAL OF KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES (BEHBOOD), vol. 20, no. 1, pp. 17–20, 2016, [Online]. Available: https://sid.ir/paper/695709/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops